155 related articles for article (PubMed ID: 19552638)
1. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.
Gluckman TJ; Segal JB; Schulman SP; Shapiro EP; Kickler TS; Prechel MM; Conte JV; Walenga JM; Shafique I; Rade JJ
J Thromb Haemost; 2009 Sep; 7(9):1457-64. PubMed ID: 19552638
[TBL] [Abstract][Full Text] [Related]
2. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
[TBL] [Abstract][Full Text] [Related]
3. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.
Gluckman TJ; McLean RC; Schulman SP; Kickler TS; Shapiro EP; Conte JV; McNicholas KW; Segal JB; Rade JJ
J Am Coll Cardiol; 2011 Mar; 57(9):1069-77. PubMed ID: 21349398
[TBL] [Abstract][Full Text] [Related]
4. Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
Bakchoul T; Assfalg V; Zöllner H; Evert M; Novotny A; Matevossian E; Friess H; Hartmann D; Hron G; Althaus K; Greinacher A; Hüser N
J Thromb Haemost; 2014 Jun; 12(6):871-8. PubMed ID: 24655935
[TBL] [Abstract][Full Text] [Related]
5. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
Une D; Kulik A; Voisine P; Le May M; Ruel M
Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.
McLean RC; Nazarian SM; Gluckman TJ; Schulman SP; Thiemann DR; Shapiro EP; Conte JV; Thompson JB; Shafique I; McNicholas KW; Villines TC; Laws KM; Rade JJ
J Cardiovasc Surg (Torino); 2011 Dec; 52(6):877-85. PubMed ID: 22051997
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
[TBL] [Abstract][Full Text] [Related]
9. The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.
Welsby IJ; Krakow EF; Heit JA; Williams EC; Arepally GM; Bar-Yosef S; Kong DF; Martinelli S; Dhakal I; Liu WW; Krischer J; Ortel TL
J Thromb Haemost; 2017 Jan; 15(1):57-65. PubMed ID: 27714919
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
11. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
[TBL] [Abstract][Full Text] [Related]
12. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
13. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
Olenchock SA; Karmpaliotis D; Gibson WJ; Murphy SA; Southard MC; Ciaglo L; Buros J; Mack MJ; Alexander JH; Harrington RA; Califf RM; Kouchoukos NT; Ferguson TB; Gibson CM
Ann Thorac Surg; 2008 Feb; 85(2):520-4. PubMed ID: 18222256
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
15. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
16. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
18. Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study.
Levine RL; Hergenroeder GW; Francis JL; Miller CC; Hursting MJ
J Thromb Thrombolysis; 2010 Aug; 30(2):142-8. PubMed ID: 19911252
[TBL] [Abstract][Full Text] [Related]
19. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
[TBL] [Abstract][Full Text] [Related]
20. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
